IDEAS home Printed from https://ideas.repec.org/a/sae/urbstu/v47y2010i13p2867-2894.html
   My bibliography  Save this article

The Pharma-biotech Complex and Interconnected Regional Innovation Arenas

Author

Listed:
  • Christian Zeller

    (Department of Geography and Geology, University of Salzburg, Hellbrunnerstrasse 34, A-5020 Salzburg, Austria, christian.zeller@sbg.ac.at)

Abstract

Large pharmaceutical firms, biotechnology firms, publicly funded research organisations and financial organisations which are inseparably connected and located in a few key regions have built a hierarchical pharma-biotech complex. It is argued that large corporations establish networks to access regionally concentrated knowledge bases. These networks consist of money flows, knowledge and personnel. By establishing such networks, large firms considerably shape and interconnect the development dynamics in the regions in which they have strategic assets. The paper reveals how the economic development trajectories of the urban regions of Basel, New Jersey and Boston are connected by large pharmaceutical firms and the industrial dynamics of the combined pharmaceutical and biotechnology industries. Such strong corporate networks result in the globally combined and interdependent development of urban regions.

Suggested Citation

  • Christian Zeller, 2010. "The Pharma-biotech Complex and Interconnected Regional Innovation Arenas," Urban Studies, Urban Studies Journal Limited, vol. 47(13), pages 2867-2894, November.
    • Handle: RePEc:sae:urbstu:v:47:y:2010:i:13:p:2867-2894
    DOI: 10.1177/0042098010377370
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0042098010377370
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0042098010377370?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Feldman, Maryann & Schreuder, Yda, 1996. "Initial Advantage: The Origins of the Geographic Concentration of the Pharmaceutical Industry in the Mid-Atlantic Region," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 5(3), pages 839-862.
    2. Walter Powell & Kenneth Koput & James Bowie & Laurel Smith-Doerr, 2002. "The Spatial Clustering of Science and Capital: Accounting for Biotech Firm-Venture Capital Relationships," Regional Studies, Taylor & Francis Journals, vol. 36(3), pages 291-305.
    3. Claude Serfati, 2008. "Financial dimensions of transnational corporations, global value chain and technological innovation," Journal of Innovation Economics, De Boeck Université, vol. 0(2), pages 35-61.
    4. Sharmistha Bagchi-Sen & Helen Lawton Smith & Linda Hall, 2004. "The US Biotechnology Industry: Industry Dynamics and Policy," Environment and Planning C, , vol. 22(2), pages 199-216, April.
    5. Ashish Arora & Robert P. Merges, 2004. "Specialized supply firms, property rights and firm boundaries," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 13(3), pages 451-475, June.
    6. repec:dau:papers:123456789/2020 is not listed on IDEAS
    7. Christian Zeller, 2004. "North Atlantic Innovative Relations of Swiss Pharmaceuticals and the Proximities with Regional Biotech Arenas," Economic Geography, Taylor & Francis Journals, vol. 80(1), pages 83-111, January.
    8. Susan Christopherson & Jennifer Clark, 2007. "Power in Firm Networks: What it Means for Regional Innovation Systems," Regional Studies, Taylor & Francis Journals, vol. 41(9), pages 1223-1236.
    9. Mowery,David C. & Nelson,Richard R. (ed.), 1999. "Sources of Industrial Leadership," Cambridge Books, Cambridge University Press, number 9780521645201.
    10. M Gray & E Parker, 1998. "Industrial Change and Regional Development: The Case of the US Biotechnology and Pharmaceutical Industries," Environment and Planning A, , vol. 30(10), pages 1757-1774, October.
    11. Andy Pike, 2006. "'Shareholder value' versus the regions: the closure of the Vaux Brewery in Sunderland," Journal of Economic Geography, Oxford University Press, vol. 6(2), pages 201-222, April.
    12. Y Schreuder, 1998. "The German-American Pharmaceutical Business Establishment in the New York Metropolitan Region," Environment and Planning A, , vol. 30(10), pages 1743-1756, October.
    13. Kean Birch, 2008. "Alliance-Driven Governance: Applying a Global Commodity Chains Approach to the U.K. Biotechnology Industry," Economic Geography, Taylor & Francis Journals, vol. 84(1), pages 83-103, January.
    14. Cooke, Phil, 2005. "Regionally asymmetric knowledge capabilities and open innovation: Exploring 'Globalisation 2'--A new model of industry organisation," Research Policy, Elsevier, vol. 34(8), pages 1128-1149, October.
    15. Gassmann, Oliver & von Zedtwitz, Maximilian, 1999. "New concepts and trends in international R&D organization," Research Policy, Elsevier, vol. 28(2-3), pages 231-250, March.
    16. Swann, G. M. Peter & Prevezer, Martha & Stout, David (ed.), 1998. "The Dynamics of Industrial Clustering: International Comparisons in Computing and Biotechnology," OUP Catalogue, Oxford University Press, number 9780198289593.
    17. Gambardella,Alfonso, 1995. "Science and Innovation," Cambridge Books, Cambridge University Press, number 9780521451185.
    18. Christian Zeller, 2002. "Project Teams as Means of Restructuring Research and Development in the Pharmaceutical Industry," Regional Studies, Taylor & Francis Journals, vol. 36(3), pages 275-289.
    19. Edward L. Glaeser, 2005. "Reinventing Boston: 1630--2003," Journal of Economic Geography, Oxford University Press, vol. 5(2), pages 119-153, April.
    20. Jason Owen-Smith & Walter W. Powell, 2004. "Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community," Organization Science, INFORMS, vol. 15(1), pages 5-21, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yunyao Li & Yanji Ma, 2022. "Research on Industrial Innovation Efficiency and the Influencing Factors of the Old Industrial Base Based on the Lock-In Effect, a Case Study of Jilin Province, China," Sustainability, MDPI, vol. 14(19), pages 1-23, October.
    2. Guido Capaldo & Margarida Fontes & Lorella Cannavacciuolo & Pierluigi Rippa & Cristina Sousa, 2015. "Networks Mobilized to Access Key Resources at Early Stages of Biotech Firms: A Comparative Analysis in Two Moderately Innovative Countries," European Planning Studies, Taylor & Francis Journals, vol. 23(7), pages 1381-1400, July.
    3. Chenxi Liu & Zhenghong Peng & Lingbo Liu & Shixuan Li, 2023. "Innovation Networks of Science and Technology Firms: Evidence from China," Land, MDPI, vol. 12(7), pages 1-21, June.
    4. Stefan Krätke, 2014. "Global Pharmaceutical and Biotechnology Firms’ Linkages in the World City Network," Urban Studies, Urban Studies Journal Limited, vol. 51(6), pages 1196-1213, May.
    5. Evgeniya Lupova-Henry & Sam Blili & Cinzia Dal Zotto, 2021. "Clusters as institutional entrepreneurs: lessons from Russia," Journal of Innovation and Entrepreneurship, Springer, vol. 10(1), pages 1-27, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Michaela Trippl & Joshua von Gabain & Franz Tödtling, 2006. "Policy agents as catalysts of knowledge links in the biotechnology sector," SRE-Disc sre-disc-2006_01, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
    2. Franz Tödtling & Michaela Trippl & Joshua von Gabain, 2006. "Clusterentwicklung und -politik im Biotechnologiesektor Wien im Kontext internationaler Erfahrungen," SRE-Disc sre-disc-2006_02, Institute for Multilevel Governance and Development, Department of Socioeconomics, Vienna University of Economics and Business.
    3. Kean Birch & Andrew Cumbers, 2010. "Knowledge, Space, and Economic Governance: The Implications of Knowledge-Based Commodity Chains for Less-Favoured Regions," Environment and Planning A, , vol. 42(11), pages 2581-2601, November.
    4. Maureen McKelvey & Bastian Rake, 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economics Research Papers 2012-021, Friedrich-Schiller-University Jena.
    5. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
    6. Sharmistha Bagchi-Sen & Helen Lawton Smith & Linda Hall, 2004. "The US Biotechnology Industry: Industry Dynamics and Policy," Environment and Planning C, , vol. 22(2), pages 199-216, April.
    7. Philip Cooke, 2010. "Global Bioregions: Knowledge Domains, Capabilities and Innovation System Networks," Chapters, in: Riccardo Viale & Henry Etzkowitz (ed.), The Capitalization of Knowledge, chapter 5, Edward Elgar Publishing.
    8. Sharmistha Bagchi-Sen & Peter Kedron & Jennifer Scully, 2011. "A Study of R&D, Collaboration, and Location Preferences of Health and Agricultural Biotech Firms," Environment and Planning C, , vol. 29(3), pages 473-486, June.
    9. Cantner, Uwe & Rake, Bastian, 2014. "International research networks in pharmaceuticals: Structure and dynamics," Research Policy, Elsevier, vol. 43(2), pages 333-348.
    10. Cooke, Phil, 2005. "Regionally asymmetric knowledge capabilities and open innovation: Exploring 'Globalisation 2'--A new model of industry organisation," Research Policy, Elsevier, vol. 34(8), pages 1128-1149, October.
    11. Tatiana Plotnikova & Bastian Rake, 2014. "Collaboration in pharmaceutical research: exploration of country-level determinants," Scientometrics, Springer;Akadémiai Kiadó, vol. 98(2), pages 1173-1202, February.
    12. Laura Wolf-Powers, 2012. "Human-capital-centred Regionalism in Economic Development: A Case of Analytics Outpacing Institutions?," Urban Studies, Urban Studies Journal Limited, vol. 49(15), pages 3427-3446, November.
    13. Philip Cooke, 2009. "The Economic Geography Of Knowledge Flow Hierarchies Among Internationally Networked Medical Bioclusters: A Scientometric Analysis," Tijdschrift voor Economische en Sociale Geografie, Royal Dutch Geographical Society KNAG, vol. 100(3), pages 332-347, July.
    14. Garavaglia Christian & Malerba Franco & Orsenigo Luigi & Pezzoni Michele, 2014. "Innovation and Market Structure in Pharmaceuticals: An Econometric Analysis on Simulated Data," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 234(2-3), pages 274-298, April.
    15. Ferretti, Marco & Guerini, Massimiliano & Panetti, Eva & Parmentola, Adele, 2022. "The partner next door? The effect of micro-geographical proximity on intra-cluster inter-organizational relationships," Technovation, Elsevier, vol. 111(C).
    16. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
    17. Al James, 2005. "Demystifying the role of culture in innovative regional economies," Regional Studies, Taylor & Francis Journals, vol. 39(9), pages 1197-1216.
    18. Chris Egeraat & Declan Curran, 2013. "Spatial Concentration in the Irish Pharmaceutical Industry: The Role of Spatial Planning and Agglomeration Economies," Tijdschrift voor Economische en Sociale Geografie, Royal Dutch Geographical Society KNAG, vol. 104(3), pages 338-358, July.
    19. Youwei Tan & Zhihui Gu & Yu Chen & Jiayun Li, 2022. "Industry Linkage and Spatial Co-Evolution Characteristics of Industrial Clusters Based on Natural Semantics—Taking the Electronic Information Industry Cluster in the Pearl River Delta as an Example," Sustainability, MDPI, vol. 14(21), pages 1-14, October.
    20. Mariana Mazzucato & Massimiliano Tancioni, 2013. "R&D, Patents and Stock Return Volatility," Economic Complexity and Evolution, in: Andreas Pyka & Esben Sloth Andersen (ed.), Long Term Economic Development, edition 127, pages 341-362, Springer.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:urbstu:v:47:y:2010:i:13:p:2867-2894. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: http://www.gla.ac.uk/departments/urbanstudiesjournal .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.